Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC

NCT06816966 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer

Interventions

RADIATION: split-course adaptive hypofractionated radiotherapy

Sponsor

Fujian Medical University Union Hospital